# Council Implementing Decision (EU) 2015/1875 of 8 October 2015 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures, Signature

Extent: E+W+S+N.I.

Done at Luxembourg, 8 October 2015.
For the Council
The President
J. Asselborn

---
Source: https://www.legislation.gov.uk/eudn/2015/1875/signature (the official version)
Page: https://openlegislation.uk/eu-decision-2015-1875/signature
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.